Table 1 Baseline characteristics of the study population by age categories (n = 136).

From: Limits of pre-endoscopic scoring systems in geriatric patients with upper gastrointestinal bleeding

 

< 82 years

(n = 67)

≥ 82 years

(n = 69)

p-value

Age, years

74.01 ± 5.44

88.10 ± 4.26

< 0.001

Sex (female)

30 (44.78)

42 (60.87)

0.060

Alcohol consumption (current drinkers)

2 (2.99)

1 (1.45)

0.542

Systolic blood pressure

119.41 ± 24.56

116.23 ± 21.29

0.424

Heart rate

89.47 ± 18.48

88.06 ± 17.78

0.652

Haemoglobin

7.71 ± 2.50

7.32 ± 2.36

0.357

Blood urea

71.80 ± 56.85

128.88 ± 201.03

0.026

Albumin

4.78 ± 2.12

3.86 ± 2.36

0.018

INR

1.61 ± 1.73

1.66 ± 1.81

0.854

Heart disease

43 (64.18)

46 (66.67)

0.760

Atrial fibrillation

20 (29.85)

30 (43.48)

0.099

Type 2 diabetes

20 (29.85)

17 (24.64)

0.495

Tumor (any)

11 (16.42)

11 (15.94)

0.940

Liver cirrhosis

5 (7.46)

4 (5.80)

0.696

PPI

37 (55.22)

36 (52.17)

0.721

Corticosteroids

4 (5.97)

3 (4.35)

0.669

Anticoagulants

22 (32.84)

28 (40.58)

0.349

Antiplatelets

27 (40.30)

30 (43.48)

0.707

EGDS findings

 Gastric ulcer

13 (19.40)

16 (23.19)

0.590

 Duodenal ulcer

13 (19.40)

17 (24.64)

0.462

 Gastritis

15 (22.39)

14 (20.29)

0.765

 Tumor

10 (14.93)

6 (8.70)

0.260

 Polyps

3 (4.48)

0 (0.00)

0.075

 Angiodysplasia

3 (4.48)

0 (0.00)

0.075

 GAVE

0 (0.00)

1 (1.45)

0.323

 Esophageal varices

4 (5.97)

2 (2.90)

0.383

EGDS timing

  

0.258

 ≤ 24 h

30 (44.78)

28 (40.58)

0.621

 24–48 h

36 (53.73)

36 (52.17)

0.856

 48–72 h

1 (1.49)

5 (7.25)

0.102

UGIB related symptoms

  

0.940

 Melena

46 (68.66)

48 (69.57)

0.909

 Hematemesis

14 (20.90)

15 (21.74)

0.904

 Melena & hematemesis

7 (10.45)

6 (8.70)

0.728

Deaths

2 (2.99)

8 (11.59)

0.054

Required RBC Transfusion

52 (77.61)

52 (75.36)

0.757

Haemostatic procedures

21 (31.34)

15 (21.74)

0.204

Rebleeding

3 (4.48)

1 (1.45)

0.296

Days of hospitalization

13.29 ± 8.01

14.52 ± 11.44

0.470

GBS score

12.79 ± 2.89

13.79 ± 2.86

0.043

mGBS score

10.70 ± 2.61

11.66 ± 2.61

0.033

MAP (ASH) score

3.46 ± 1.29

4.08 ± 1.41

0.008

CANUKA score

7.64 ± 1.88

8.04 ± 1.99

0.230

T-score

8.38 ± 1.66

8.14 ± 1.45

0.364

AIMS65 score

1.53 ± 0.63

1.87 ± 0.74

< 0.001

  1. Data are presented as means ± standard deviations or number (%).
  2. INR international normalized ratio, PPI proton pump inhibitors, EGDS Esophagogastroduodenoscopy, RBC red blood cells, GBS Glasgow-Blatchford Bleeding, mGBS modified Glasgow-Blatchford Bleeding, CANUKA Canada–United Kingdom–Adelaide, GAVE Gastric antral vascular ectasia.